Hydroxyurea Chemotherapy for Unresectable or Residual Meningioma
- 1 January 2000
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 49 (2) , 165-170
- https://doi.org/10.1023/a:1026770624783
Abstract
Meningiomas represent 18–20% of all intracranial tumors and have a 10-year recurrence rate of 20–50%, despite aggressive surgery and irradiation. In addition, many tumors are not amenable to surgery...Keywords
This publication has 16 references indexed in Scilit:
- Long-term outcomes after meningioma radiosurgery: physician and patient perspectivesJournal of Neurosurgery, 1999
- Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathwayJournal of Neurosurgery, 1997
- Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyureaJournal of Neurosurgery, 1997
- Perspective: The Chemotherapeutic Relevance of Apoptosis and a Proposed Biochemical Cascade for Chemotherapeutically Induced ApoptosisCancer Investigation, 1997
- Mechanisms of Apoptosis: Integration of Genetic, Biochemical, and Cellular IndicatorsJNCI Journal of the National Cancer Institute, 1994
- Epidemiology of intracranial meningiomaCancer, 1993
- Mifepristone (RU 486) treatment of meningiomas.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Treatment of unresectable meningiomas with the antiprogesterone agent mifepristoneJournal of Neurosurgery, 1991
- Incidence and clinicopathological features of meningiomaJournal of Neurosurgery, 1989
- Meningioma: analysis of recurrence and progression following neurosurgical resectionJournal of Neurosurgery, 1985